-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Kso7AGGPUFNPniLTRxBXAWKdTgivoARrINwG7kZ8G8biyBJo6S1V1Xh9jjOBA2KT bjBvWCCPiQMS9cFxD/ayAw== 0001144204-11-002097.txt : 20110113 0001144204-11-002097.hdr.sgml : 20110113 20110113150131 ACCESSION NUMBER: 0001144204-11-002097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110113 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20110113 DATE AS OF CHANGE: 20110113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioDrain Medical, Inc. CENTRAL INDEX KEY: 0001446159 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 331007393 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-155299 FILM NUMBER: 11527406 BUSINESS ADDRESS: STREET 1: 2060 CENTRE POINTE BOULEVARD STREET 2: SUITE 7 CITY: MENDOTA HEIGHTS STATE: MN ZIP: 55120 BUSINESS PHONE: (612) 850-9460 MAIL ADDRESS: STREET 1: 2060 CENTRE POINTE BOULEVARD STREET 2: SUITE 7 CITY: MENDOTA HEIGHTS STATE: MN ZIP: 55120 8-K 1 v208077_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  January 13, 2011 (January 13, 2011)

BioDrain Medical, Inc.
(Exact name of Registrant as Specified in its Charter)

Minnesota
(State or Other Jurisdiction of Incorporation)

333-155299
33-1007393
(Commission File Number)
(IRS Employer Identification No.)
 
2060 Centre Pointe Boulevard, Suite 7
Mendota Heights, Minnesota 55120
(Address of Principal Executive Offices and Zip Code)

(651) 389-4800              (651) 389-4800
(Registrant’s telephone number, including area code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
           
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) 
Departure of Officer or Director

Effective January 13, 2011, James E. Dauwalter resigned as a member of the Registrant’s Board of Directors for personal reasons.  Mr. Dauwalter has no disagreement with management or other directors of the Registrant and is supportive of its plans for growth.

 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 13, 2011
 
 
BIODRAIN MEDICAL, INC.
  
       
 
By:
/s/ Kevin R. Davidson
  
   
Kevin R. Davidson
  
   
Chief Executive Officer,
  
 
 
 
 
-----END PRIVACY-ENHANCED MESSAGE-----